Inventor

Thomas E. Rogers

Inventor
Ballwin, MO, US

Overview

48→
Patents
1980–2020
Patent span
Chemistry
Primary field (CPC C)

Patents· 48 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Dprimary
C07DHeterocyclic compounds22%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations21%
C07CAcyclic or carbocyclic compounds11%
A61KPreparations for medical, dental or toiletry purposes10%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium9%
C07KPeptides5%
C07HSugars4%
C25BElectrolytic or electrophoretic processes for the production of compounds or non-metals3%
Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests2%
B21JForging2%
PatentTitleYear
10,525,149Compositions and methods for assessing eye vasculature20209,216,225'Remote assembly of targeted nanoparticles using H-phosphate ENE/-YNE hydrophosphonylation reactions'20158,889,657'Nanoparticle PEG modification with H-phosphonates'20148,871,189'MMP-targeted therapeutic and/or diagnostic nanocarriers'20147,569,572'Pyrazolo[4,3-D]pyrimidines'2009D0544941'Collapsible structure'20076,949,578'Cycloalkyl alkanoic acids as integrin receptor antagonists'20056,921,767'Cycloalkyl alkanoic acids as integrin receptor antagonists derivatives'20056,906,051'Lactone integrin antagonists'20056,900,232'Cycloalkyl alkanoic acids as integrin receptor antagonists'20056,833,366'Dihydrostilbene alkanoic acid derivatives'20046,831,199'Pyrimidine compounds and derivatives thereof'20046,808,877'Ligands for FPR class receptors that induce a host immune response to a pathogen or inhibit HIV infection'20046,720,327'Lactone integrin antagonists'20046,720,315'Dihydrostilbene alkanoic acid derivatives'20046,689,754'Heterocyclic glycyl -alanine derivatives'20046,531,494'Gem-substituted v3 antagonists'20036,372,719'3 integrin antagonists in combination with chemotherapeutic agents'20026,251,944'Para-substituted phenylene derivatives'20016,100,423'Amino benzenepropanoic acid compounds and derivatives thereof'20006,037,365'Aminobenzamidinosuccinyl lactone derivatives useful as inhibitors of platelet aggregation'20006,028,223'Meta-guanidine, urea, thiourea or azacyclic amino benzoic acid compounds and derivatives thereof'20006,013,651'Meta-azacyclic amino benzoic acid compounds and derivatives thereof'20005,973,003'Substituted .beta.-amino acid derivatives useful as platelet aggregation inhibitors'19995,952,381'Para-substituted phenylene derivatives'19995,886,208'Substituted B-amino acid derivatives useful as platelet aggregation inhibitors'19995,874,612'Process for the preparation of glyphosate and glyphosate derivatives'19995,811,398'Platelet aggregation inhibitors containing C-terminal aminergic side chain amino acid residues'19985,703,125'Substituted .beta.-amino acid derivatives useful as platelet aggregation inhibitors'19975,625,093'Substituted .beta.-amino acid derivatives useful as platelet aggregation inhibitors'19975,578,190'Process for the preparation of glyphosate and glyphosate derivatives'19965,550,159'Peptide mimics useful as platelet aggregation inhibitors'19965,489,594'Platelet aggregation inhibitors'19965,453,440'Peptide mimics useful as platelet aggregation inhibitors'19955,441,974'Phenyl amidines lactones useful as platelet aggregation inhibitors'19955,430,043'Platelet aggregation inhibitors'19955,378,727'Substituted bicyclic heterocyclic compounds useful as platelet aggregation inhibitors'19955,359,053'Modified deazapyrimidines'19945,344,957'Substituted .beta.-amino acid derivatives useful as platelet aggregation inhibitors'19945,254,573'Substituted heterocyclic derivatives useful as platelet aggregation inhibitors'19935,239,113'Substituted .beta.-amino acid derivatives useful as platelet aggregation inhibitors and intermediates thereof'19935,134,066'Improved probes using nucleosides containing 3-dezauracil analogs'19924,568,432'Process for preparing glyphosate and glyphosate derivatives'19864,526,990'Synthesis of .gamma.-vinyl-.gamma.-butyrolactone from acetoxyhexenoic acids'19854,457,813'Electrolysis cells and electrolytic processes'19844,246,388'Initiation of anionic polymerization of vinyl monomers by reduced graphite'19814,204,421'Laminated board and hammer combination for a drop hammer forge'19804,204,420'Laminated board and hammer combination for a drop hammer forge'1980

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1980Patents assigned to MARION PLYWOOD CORP (2)· patent assignee history
1980Based in Marion, WI, US· patent location history
1981–1997Patents assigned to MONSANTO CO (10)· patent assignee history
1984–1999Based in Manchester, MO, US· patent location history
1993–2004Patents assigned to SEARLE & CO (23)· patent assignee history
1993–2020Based in Ballwin, MO, US· patent location history
2003–2005Patents assigned to PHARMACIA CORP (8)· patent assignee history
2004Based in North Wales, PA, US· patent location history
2007Based in White River Country Estate, White River, ZA· patent location history
2014–2015Patents assigned to MALLINCKRODT LLC (3)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
SEARLE & CO231993–2004
MONSANTO CO101981–1997
PHARMACIA CORP82003–2005
MALLINCKRODT LLC32014–2015
MARION PLYWOOD CORP21980
Locations
LocationPatentsSpan
Ballwin, MO, US361993–2020
Manchester, MO, US71984–1999
Marion, WI, US21980
White River Country Estate, White River, ZA12007
North Wales, Pennsylvania, US12004